Premkumar M, Devurgowda D, Vyas T, et al. Left ventricular diastolic dysfunction is associated with renal dysfunction, poor survival and low health related quality of life in cirrhosis. J Clin Exp Hepatol. 2019;9(3):324–333

Article  PubMed  Google Scholar 

Liu H, Naser JA, Lin G, Lee SS. Cardiomyopathy in cirrhosis: from pathophysiology to clinical care. JHEP Rep. 2023;6(1): 100911

Article  PubMed  PubMed Central  Google Scholar 

Izzy M, VanWagner LB, Lee SS, Altieri M, Angirekula M, Watt KD. Understanding and managing cardiovascular outcomes in liver transplant recipients. Curr Opin Organ Transplant. 2019;24(2):148–155

Article  PubMed  PubMed Central  Google Scholar 

Liu H, Jayakumar S, Traboulsi M, Lee SS. Cirrhotic cardiomyopathy: implications for liver transplantation. Liver Transpl. 2017;23(6):826–835

Article  PubMed  Google Scholar 

Desai MS, Zainuer S, Kennedy C, Kearney D, Goss J, Karpen SJ. Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation. Gastroenterology. 2011;141(4):1264-1272.e12724

Article  PubMed  Google Scholar 

Gorgis NM, Kennedy C, Lam F, et al. Clinical consequences of cardiomyopathy in children with biliary atresia requiring liver transplantation. Hepatology. 2019;69(3):1206–1218

Article  PubMed  CAS  Google Scholar 

Morrison J, Ferguson E, Figueroa J, Karpen SJ. Features of cirrhotic cardiomyopathy early in the lives of infants with biliary atresia correlate with outcomes following Kasai portoenterostomy. Hepatol Commun. 2022;6(6):1413–1424

Article  PubMed  PubMed Central  Google Scholar 

Jang DM, Jun IG, Moon YJ, Shin WJ, Song JG, Hwang GS. Pretransplant left ventricular dysfunction adversely affects perioperative outcomes in pediatric liver transplantation: a retrospective observational study. Transplant Proc. 2016;48(10):3328–3335

Article  PubMed  Google Scholar 

Junge N, Junge C, Schröder J, et al. Pediatric cirrhotic cardiomyopathy: impact on liver transplant outcomes. Liver Transpl. 2018;24(6):820–830

Article  PubMed  Google Scholar 

Khemakanok K, Khositseth A, Treepongkaruna S, et al. Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation. Hepatol Int. 2016;10(3):518–524

Article  PubMed  Google Scholar 

Li T, Wei X, Hao X, et al. Subclinical cardiac abnormalities in children with biliary atresia correlate with outcomes after liver transplantation. Front Pediatr. 2023;11:1174357

Article  PubMed  PubMed Central  Google Scholar 

Brito MM, Miyatani HT, de Alencar Pereira PR, Tannuri ACA, Tannuri U. Evaluation of ventricular systolic function by speckle tracking technique in patients with biliary atresia before and after liver transplantation. Sci Rep. 2021;11(1):17807

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gottdiener JS, Bednarz J, Devereux R, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr. 2004;17(10):1086–1119

PubMed  Google Scholar 

Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–458

Article  PubMed  CAS  Google Scholar 

Izzy M, VanWagner LB, Lin G, et al. Redefining Cirrhotic Cardiomyopathy for the Modern Era [published correction appears in Hepatology. 2020 Sep;72(3):1161. https://doi.org/10.1002/hep.31463]. Hepatology. 2020;71(1):334–45.

Kaur H, Premkumar M. Diagnosis and management of cirrhotic cardiomyopathy. J Clin Exp Hepatol. 2022;12(1):186–199

Article  PubMed  CAS  Google Scholar 

Zardi EM, Zardi DM, Chin D, Sonnino C, Dobrina A, Abbate A. Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase. J Cardiol. 2016;67(2):125–130

Article  PubMed  Google Scholar 

Carvalho MVH, Kroll PC, Kroll RTM, Carvalho VN. Cirrhotic cardiomyopathy: the liver affects the heart. Braz J Med Biol Res. 2019;52(2): e7809

Article  PubMed  PubMed Central  CAS  Google Scholar 

Virk MK, Mian MUM, Bashir DA, et al. Elevated bile acids are associated with left ventricular structural changes in biliary atresia. Hepatol Commun. 2023;7(5): e0109

Article  PubMed  PubMed Central  Google Scholar 

Desai MS, Mathur B, Eblimit Z, et al. Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart. Hepatology. 2017;65(1):189–201

Article  PubMed  CAS  Google Scholar 

Desai MS, Eblimit Z, Thevananther S, et al. Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis. Liver Int. 2015;35(4):1464–1477

Article  PubMed  CAS  Google Scholar 

Desai MS, Shabier Z, Taylor M, et al. Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis. Hepatology. 2010;51(6):2097–2107

Article  PubMed  CAS  Google Scholar 

Chatterjee S, Bijsmans IT, van Mil SW, Augustijns P, Annaert P. Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates. Toxicol In Vitro. 2014;28(2):218–230

Article  PubMed  CAS  Google Scholar 

Risteska M, Vladimirova-Kitova L, Andonov V. Serum NT-ProBNP potential marker of cirrhotic cardiomyopathy. Folia Med (Plovdiv). 2022;64(5):740–745

Article  PubMed  CAS  Google Scholar 

Kapoor N, Mehta V, Singh B, Karna R, Kumar S, Kar P. Prevalence of cirrhotic cardiomyopathy and its relationship with serum pro-brain natriuretic peptide, hepatorenal syndrome, spontaneous bacterial peritonitis, and mortality. Indian J Gastroenterol. 2020;39(5):481–486

Article  PubMed  CAS  Google Scholar 

Henriksen JH, Gøtze JP, Fuglsang S, Christensen E, Bendtsen F, Møller S. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut. 2003;52(10):1511–1517

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mihailovici AR, Donoiu I, Gheonea DI, et al. NT-proBNP and echocardiographic parameters in liver cirrhosis—correlations with disease severity. Med Princ Pract. 2019;28(5):432–441

Article  PubMed  PubMed Central  Google Scholar 

Krag A, Bendtsen F, Henriksen JH, Møller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut. 2010;59(1):105–110

Article  PubMed  CAS  Google Scholar 

Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas SD. Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis. Hepatol Int. 2014;8(4):588–594

Article  PubMed  Google Scholar 

Behera MK, Swain SN, Sahu MK, et al. Diastolic dysfunction is a predictor of poor survival in patients with decompensated cirrhosis. Int J Hepatol. 2021;2021: 5592376

Article  PubMed  PubMed Central  Google Scholar